Figure 1.
Dexcom G4 Platinum continuous glucose monitor tracings A, before, and B, after pasireotide addition, showing a reduction in glucose readings of less than 70 mg/dL from 30% to 3% of recorded values, respectively.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.